Filter
249
Filtered Results: 249
Text search:
Ministry
of
Health
Saudi
Arabia
Featured
Recommendations
19
New Publications
50
Language
Document type
No document type
113
Studies & Reports
70
Guidelines
31
Strategic & Response Plan
12
Manuals
8
Situation Updates
6
Resource Platforms
4
Fact sheets
3
Training Material
1
Videos
1
Countries / Regions
Global
30
Yemen
14
Syria
7
Kenya
6
Ethiopia
5
Middle East and North Africa
5
Saudi Arabia
4
India
4
South Sudan
4
Bangladesh
4
Myanmar / Burma
4
Nigeria
3
Uganda
3
Somalia
3
Cambodia
3
China
3
South–East Asia Region
3
Africa
3
Burkina Faso
2
Sierra Leone
2
Mali
2
Nepal
2
Pakistan
2
Iraq
2
Afghanistan
2
Thailand
2
Indonesia
2
Mozambique
2
Greece
2
Mexico
2
Asia
2
Palestine
2
Guinea
1
Liberia
1
Congo, Democratic Republic of
1
Morocco
1
Ghana
1
Philippines
1
Jordan
1
Germany
1
Lebanon
1
Rwanda
1
South Africa
1
Malawi
1
Sudan
1
Central African Republic
1
Burundi
1
Ecuador
1
Botswana
1
Libya
1
East and Southern Africa
1
Latin America and the Carribbean
1
Western and Central Europe
1
Venezuela
1
Eastern Europe
1
Albania
1
Djibouti
1
Armenia
1
Laos
1
Russia
1
Iran
1
Georgia
1
Vietnam
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
60
Public Health
25
Clinical Guidelines
20
Key Resources
11
Women & Child Health
10
Capacity Building
6
Pharmacy & Technologies
2
Toolboxes
COVID-19
38
Mental Health
27
Conflict
13
Refugee
13
HIV
13
Rapid Response
12
AMR
12
Planetary Health
9
TB
8
Health Financing Toolbox
8
Pharmacy
7
NTDs
7
Disability
6
NCDs
6
Global Health Education
5
Caregiver
5
Ebola
4
Polio
3
Cholera
2
Natural Hazards
1
Specific Hazards
1
Social Ethics
1
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those wi...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different ...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioec...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as ... 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection ...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, surveillance and ... systems response that will allow NCDs and their contributing risk factors to be successfully contained and reversed.
This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of...
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the ...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These g...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Su...
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public ... planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform national planning efforts and decisions. Multifaceted approaches, including scaling up interventions to address modifiable risk factors and investing in research on biological mechanisms, will be key in addressing the expected increases in the number of individuals affected by dementia.
Globalization and Health 2012, 8:15
Experience of national TB partnerships
